| # | Drug | Count |
|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 16219 |
| 1 | METOCLOPRAMIDE | 13206 |
| 2 | ARIPIPRAZOLE | 2905 |
| 3 | QUETIAPINE | 1915 |
| 4 | RISPERIDONE | 1760 |
| 5 | VALBENAZINE | 1537 |
| 6 | OLANZAPINE | 1143 |
| 7 | CLONAZEPAM | 776 |
| 8 | ZIPRASIDONE | 707 |
| 9 | ARIPIPRAZOLE ORAL | 683 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 16219 | 0.2087 |
| 1 | ZIPRASIDONE | 707 | 0.1962 |
| 2 | THIORIDAZINE HYDROCHLORIDE | 5 | 0.0893 |
| 3 | VALBENAZINE | 1537 | 0.0605 |
| 4 | PERPHENAZINE | 101 | 0.0484 |
| 5 | THIOTHIXENE | 10 | 0.0459 |
| 6 | ZIPRASIDONE MESYLATE | 632 | 0.0445 |
| 7 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 4 | 0.0408 |
| 8 | CARIPRAZINE | 392 | 0.0407 |
| 9 | BREXPIPRAZOLE | 603 | 0.0357 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 6868 |
| 1 | Benzodiazepine [EPC] | 1839 |
| 2 | Anti-epileptic Agent [EPC] | 784 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 747 |
| 4 | Mood Stabilizer [EPC] | 706 |
| 5 | Proton Pump Inhibitor [EPC] | 547 |
| 6 | Typical Antipsychotic [EPC] | 395 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 363 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 353 |
| 9 | Corticosteroid [EPC] | 323 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 163 | 0.1315 |
| 1 | Typical Antipsychotic [EPC] | 395 | 0.0158 |
| 2 | Atypical Antipsychotic [EPC] | 6868 | 0.0152 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 22 | 0.0106 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 75 | 0.0096 |
| 5 | Provitamin D2 Compound [EPC] | 267 | 0.0090 |
| 6 | Phenothiazine [EPC] | 149 | 0.0050 |
| 7 | Influenza A M2 Protein Inhibitor [EPC] | 65 | 0.0041 |
| 8 | Nonergot Dopamine Agonist [EPC] | 64 | 0.0041 |
| 9 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 13 | 0.0036 |